(-)-demecolcine decreases expression ISO RGD:1319734 6480464 Demecolcine results in decreased expression of FBXO5 mRNA CTD PMID:23649840 17beta-estradiol increases expression ISO RGD:1319734 6480464 Estradiol results in increased expression of FBXO5 mRNA CTD PMID:16474171 , PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1319735 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1319735 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319734 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBXO5 mRNA CTD PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBXO5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FBXO5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319734 6480464 Tetrachlorodibenzodioxin affects the expression of FBXO5 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319735 6480464 Tetrachlorodibenzodioxin affects the expression of FBXO5 mRNA CTD PMID:21570461 2-methylcholine affects expression ISO RGD:1319734 6480464 beta-methylcholine affects the expression of FBXO5 mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1319735 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of FBXO5 mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol increases methylation ISO RGD:1319734 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of FBXO5 gene CTD PMID:31601247 4-hydroxynon-2-enal decreases expression ISO RGD:1319735 6480464 4-hydroxy-2-nonenal results in decreased expression of FBXO5 mRNA CTD PMID:19191707 4-hydroxynon-2-enal increases expression ISO RGD:1319735 6480464 4-hydroxy-2-nonenal results in increased expression of FBXO5 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1319735 6480464 Fenretinide results in increased expression of FBXO5 mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:1319734 6480464 Fluorouracil results in decreased expression of FBXO5 mRNA CTD PMID:16557594 5-fluorouracil decreases expression ISO RGD:1319735 6480464 Fluorouracil results in decreased expression of FBXO5 mRNA CTD PMID:19272435 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FBXO5 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of FBXO5 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1319734 6480464 Acrylamide results in decreased expression of FBXO5 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1319734 6480464 Aflatoxin B1 affects the expression of FBXO5 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1319734 6480464 Aflatoxin B1 results in increased expression of FBXO5 mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:1319734 6480464 Aflatoxin B1 results in decreased methylation of FBXO5 gene CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of FBXO5 mRNA CTD PMID:23630614 aflatoxin B1 increases expression ISO RGD:1319735 6480464 Aflatoxin B1 results in increased expression of FBXO5 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1319734 6480464 Tretinoin results in decreased expression of FBXO5 mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO RGD:1319734 6480464 Antirheumatic Agents results in decreased expression of FBXO5 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1319734 6480464 aristolochic acid I results in decreased expression of FBXO5 mRNA CTD PMID:33212167 azathioprine decreases expression ISO RGD:1319734 6480464 Azathioprine results in decreased expression of FBXO5 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1319734 6480464 Benzo(a)pyrene results in decreased expression of FBXO5 mRNA CTD PMID:21632981 more ... benzo[a]pyrene increases expression ISO RGD:1319734 6480464 Benzo(a)pyrene results in increased expression of FBXO5 mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1319734 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1319735 6480464 benzo(b)fluoranthene results in increased expression of FBXO5 mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1319734 6480464 Mustard Gas results in decreased expression of FBXO5 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:1319734 6480464 bisphenol A results in increased expression of FBXO5 mRNA CTD PMID:16474171 bisphenol A decreases methylation ISO RGD:1319734 6480464 bisphenol A results in decreased methylation of FBXO5 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1319734 6480464 bisphenol A results in decreased expression of FBXO5 mRNA CTD PMID:29275510 bisphenol A affects expression ISO RGD:1319734 6480464 bisphenol A affects the expression of FBXO5 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FBXO5 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBXO5 mRNA CTD PMID:25181051 cadmium atom decreases expression ISO RGD:1319734 6480464 Cadmium results in decreased expression of FBXO5 mRNA CTD PMID:21120746 caffeine decreases phosphorylation ISO RGD:1319734 6480464 Caffeine results in decreased phosphorylation of FBXO5 protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:1319734 6480464 Calcitriol results in decreased expression of FBXO5 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1319734 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of FBXO5 mRNA CTD PMID:21592394 captan decreases expression ISO RGD:1319735 6480464 Captan results in decreased expression of FBXO5 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1319734 6480464 Carbamazepine affects the expression of FBXO5 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1319735 6480464 Nanotubes, Carbon affects the expression of FBXO5 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1319735 6480464 Nanotubes, Carbon analog results in increased expression of FBXO5 mRNA CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of FBXO5 mRNA CTD PMID:18500788 chromium(6+) multiple interactions ISO RGD:1319734 6480464 [Nocodazole co-treated with chromium hexavalent ion] results in decreased expression of FBXO5 protein CTD PMID:21670593 cisplatin increases expression ISO RGD:1319734 6480464 Cisplatin results in increased expression of FBXO5 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1319734 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of FBXO5 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1319734 6480464 cobaltous chloride results in decreased expression of FBXO5 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1319734 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FBXO5 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1319734 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FBXO5 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1319734 6480464 Copper Sulfate results in decreased expression of FBXO5 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1319734 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1319734 6480464 Coumestrol results in increased expression of FBXO5 mRNA CTD PMID:19167446 crotonaldehyde decreases expression ISO RGD:1319734 6480464 2-butenal results in decreased expression of FBXO5 mRNA CTD PMID:20471460 CU-O LINKAGE decreases expression ISO RGD:1319734 6480464 cupric oxide results in decreased expression of FBXO5 mRNA CTD PMID:22077320 cyclosporin A affects expression ISO RGD:1319734 6480464 Cyclosporine affects the expression of FBXO5 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1319734 6480464 Cyclosporine results in increased expression of FBXO5 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1319734 6480464 Cyclosporine results in decreased expression of FBXO5 mRNA CTD PMID:21632981 , PMID:25562108 diazinon increases methylation ISO RGD:1319734 6480464 Diazinon results in increased methylation of FBXO5 gene CTD PMID:22964155 dibenz[a,h]anthracene increases expression ISO RGD:1319735 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1319735 6480464 Dibutyl Phthalate results in decreased expression of FBXO5 mRNA CTD PMID:17361019 , PMID:21266533 diclofenac decreases expression ISO RGD:1319735 6480464 Diclofenac results in decreased expression of FBXO5 mRNA CTD PMID:35537566 disodium selenite decreases expression ISO RGD:1319734 6480464 Sodium Selenite results in decreased expression of FBXO5 mRNA CTD PMID:24383545 dorsomorphin multiple interactions ISO RGD:1319734 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1319734 6480464 Doxorubicin results in decreased expression of FBXO5 mRNA CTD PMID:29803840 Echimidine multiple interactions ISO RGD:1319734 6480464 [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of FBXO5 mRNA CTD PMID:33884520 Enterolactone multiple interactions ISO RGD:1319734 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA CTD PMID:19167446 folpet decreases expression ISO RGD:1319735 6480464 folpet results in decreased expression of FBXO5 mRNA CTD PMID:31558096 fulvestrant multiple interactions ISO RGD:1319734 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of FBXO5 mRNA CTD PMID:19016759 fulvestrant decreases expression ISO RGD:1319734 6480464 fulvestrant results in decreased expression of FBXO5 mRNA CTD PMID:19016759 furan increases methylation EXP 6480464 furan results in increased methylation of FBXO5 gene CTD PMID:22079235 genistein increases expression ISO RGD:1319734 6480464 Genistein results in increased expression of FBXO5 mRNA CTD PMID:16474171 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of FBXO5 mRNA CTD PMID:33387578 geraniol decreases expression ISO RGD:1319734 6480464 geraniol results in decreased expression of FBXO5 mRNA CTD PMID:27683099 hydroquinone decreases expression ISO RGD:1319734 6480464 hydroquinone results in decreased expression of FBXO5 mRNA CTD PMID:23416264 Lasiocarpine multiple interactions ISO RGD:1319734 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of FBXO5 mRNA CTD PMID:33884520 leflunomide decreases expression ISO RGD:1319734 6480464 leflunomide results in decreased expression of FBXO5 mRNA CTD PMID:28988120 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of FBXO5 mRNA CTD PMID:35283115 lucanthone decreases expression ISO RGD:1319734 6480464 Lucanthone results in decreased expression of FBXO5 mRNA CTD PMID:21148553 methyl methanesulfonate increases expression ISO RGD:1319734 6480464 Methyl Methanesulfonate results in increased expression of FBXO5 mRNA CTD PMID:23649840 monocrotaline multiple interactions ISO RGD:1319734 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of FBXO5 mRNA CTD PMID:33884520 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1319734 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FBXO5 mRNA CTD PMID:24810058 N-methyl-N-nitrosourea increases expression ISO RGD:1319735 6480464 Methylnitrosourea results in increased expression of FBXO5 mRNA CTD PMID:25270620 N-Nitrosopyrrolidine decreases expression ISO RGD:1319734 6480464 N-Nitrosopyrrolidine results in decreased expression of FBXO5 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1319734 6480464 Nickel results in increased expression of FBXO5 mRNA CTD PMID:25583101 nocodazole multiple interactions ISO RGD:1319734 6480464 [Nocodazole co-treated with chromium hexavalent ion] results in decreased expression of FBXO5 protein CTD PMID:21670593 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FBXO5 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of FBXO5 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1319735 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FBXO5 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FBXO5 mRNA CTD PMID:34911549 paclitaxel affects expression ISO RGD:1319734 6480464 Paclitaxel affects the expression of FBXO5 protein CTD PMID:27769712 palbociclib decreases expression ISO RGD:1319734 6480464 palbociclib results in decreased expression of FBXO5 mRNA CTD PMID:22869556 paracetamol increases expression ISO RGD:1319734 6480464 Acetaminophen results in increased expression of FBXO5 mRNA CTD PMID:22230336 PCB138 multiple interactions ISO RGD:1319735 6480464 [2 more ... CTD PMID:25510870 phenobarbital affects expression ISO RGD:1319735 6480464 Phenobarbital affects the expression of FBXO5 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1319734 6480464 Phenylmercuric Acetate results in decreased expression of FBXO5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1319734 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO5 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1319735 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FBXO5 mRNA CTD PMID:19710929 propanal decreases expression ISO RGD:1319734 6480464 propionaldehyde results in decreased expression of FBXO5 mRNA CTD PMID:26079696 quercetin decreases expression ISO RGD:1319734 6480464 Quercetin results in decreased expression of FBXO5 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1319734 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of FBXO5 mRNA CTD PMID:19167446 riddelliine multiple interactions ISO RGD:1319734 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of FBXO5 mRNA CTD PMID:33884520 rotenone decreases expression ISO RGD:1319734 6480464 Rotenone results in decreased expression of FBXO5 mRNA CTD PMID:29955902 , PMID:33512557 SB 431542 multiple interactions ISO RGD:1319734 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1319734 6480464 Silicon Dioxide results in decreased expression of FBXO5 mRNA CTD PMID:25351596 silicon dioxide increases expression ISO RGD:1319735 6480464 Silicon Dioxide results in increased expression of FBXO5 mRNA CTD PMID:29341224 silver atom decreases expression ISO RGD:1319734 6480464 Silver results in decreased expression of FBXO5 mRNA CTD PMID:26014281 silver(0) decreases expression ISO RGD:1319734 6480464 Silver results in decreased expression of FBXO5 mRNA CTD PMID:26014281 sirolimus multiple interactions ISO RGD:1319734 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of FBXO5 mRNA CTD PMID:19016759 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of FBXO5 mRNA CTD PMID:22110744 sodium dichromate decreases expression ISO RGD:1319735 6480464 sodium bichromate results in decreased expression of FBXO5 mRNA CTD PMID:31558096 sodium dodecyl sulfate decreases expression ISO RGD:1319734 6480464 Sodium Dodecyl Sulfate results in decreased expression of FBXO5 mRNA CTD PMID:31734321 sunitinib decreases expression ISO RGD:1319734 6480464 Sunitinib results in decreased expression of FBXO5 mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1319734 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of FBXO5 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1319734 6480464 Testosterone results in decreased expression of FBXO5 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1319735 6480464 Carbon Tetrachloride results in increased expression of FBXO5 mRNA CTD PMID:17484886 , PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FBXO5 mRNA CTD PMID:23411599 , PMID:34492290 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of FBXO5 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FBXO5 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of FBXO5 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1319734 6480464 trichostatin A results in decreased expression of FBXO5 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1319734 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO5 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1319735 6480464 trimellitic anhydride results in increased expression of FBXO5 mRNA CTD PMID:19042947 trovafloxacin decreases expression ISO RGD:1319735 6480464 trovafloxacin results in decreased expression of FBXO5 mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:1319735 6480464 Tungsten results in increased expression of FBXO5 mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:1319734 6480464 Urethane results in decreased expression of FBXO5 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1319735 6480464 Valproic Acid results in decreased expression of FBXO5 mRNA CTD PMID:15799026 valproic acid decreases expression ISO RGD:1319734 6480464 Valproic Acid results in decreased expression of FBXO5 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1319734 6480464 Valproic Acid affects the expression of FBXO5 mRNA CTD PMID:25979313 vanadyl sulfate decreases expression ISO RGD:1319734 6480464 vanadyl sulfate results in decreased expression of FBXO5 mRNA CTD PMID:16330358 vincristine decreases expression ISO RGD:1319734 6480464 Vincristine results in decreased expression of FBXO5 mRNA CTD PMID:23649840 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of FBXO5 mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO RGD:1319735 6480464 squalestatin 1 results in decreased expression of FBXO5 mRNA CTD PMID:27225895